AXL and cancer: Notably, differences in AXL-targeting siRNA efficacy were observed, with siAXL #47 performing better in well-differentiated AXL + PLC-PRF-5 cancer cells, while siAXL #45 was more effective in AXL+ high-grade SNU449 cells (Suppl.